Xiao, Cheng
Chen, Fang
Cao, Lei
Yang, Ming
Tan, Yuting
Lin, Guoyun
Yang, Guiying
Jing, Sheng
Li, Hong
Funding for this research was provided by:
National Natural Science Foundation of China (Project No.82171265)
Article History
Received: 19 February 2024
Accepted: 18 June 2024
First Online: 2 July 2024
Declarations
:
: The study protocol was approved by the China Clinical Trial Register ChiCTR2300068584. Registered on 24 February 2023. Participants will be informed of the purpose, risks, and benefits of the study, and a written informed consent will be obtained. Participation is entirely voluntary. Informed consent materials are available upon request from principal investigator.
: Patients will be informed about the purpose, risks, and benefits of the study. Written informed consent will be obtained from the patients or legal representatives. No identifying images or other personal or clinical details of the participants are provided here, nor will they be included in the report of the trial results. Informed consent materials are available from the corresponding author upon request.
: The authors declare that they have no competing interests.